While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in the tumor microenvironment.
Can childhood traumas affect pandemic resilience? Study investigates connection between adverse experiences and mental, physical health during COVID-19
Researchers investigated whether changes in sleep quality, physical health, and mental health reported across the initial COVID-19 were related to ACEs.
August 29, 2023